Literature DB >> 8442582

Deposition in asthmatics of particles inhaled in air or in helium-oxygen.

M Anderson1, M Svartengren, G Bylin, K Philipson, P Camner.   

Abstract

Ten subjects with asthma inhaled 3.6 micron particles labeled with 111In in air and in a helium-oxygen mixture (He-O2) at 0.5 and at 1.2 L/s. Lung retention was measured after zero and after 24 h, and the percentage 24-h retention (Ret24) was taken to represent the fraction deposited in the alveolar part of the lung. For both inhalation rates, Ret24 was significantly higher when particles were inhaled with He-O2 than with air. The increase in Ret24 seemed to be larger in subjects with asthma than in healthy persons earlier studied. Ret24 was correlated with changes in both large and small airways, especially when the particles were inhaled with He-O2. Our data suggest that inhalation of drugs in He-O2 might be of therapeutic value when treating patients with severely obstructed airways.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8442582     DOI: 10.1164/ajrccm/147.3.524

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  16 in total

Review 1.  Management of acute pediatric asthma.

Authors:  John C Carl; Carolyn M Kercsmar
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

Review 2.  Aerosol deposition in health and disease.

Authors:  Chantal Darquenne
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-06       Impact factor: 2.849

3.  Aerosol deposition in the human respiratory tract breathing air and 80:20 heliox.

Authors:  Chantal Darquenne; G Kim Prisk
Journal:  J Aerosol Med       Date:  2004

4.  Aerosol deposition in the human lung periphery is increased by reduced-density gas breathing.

Authors:  Jonathan B Peterson; G Kim Prisk; Chantal Darquenne
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2008-06       Impact factor: 2.849

Review 5.  Drug therapy approaches in the treatment of acute severe asthma in hospitalised children.

Authors:  L K DeNicola; M O Gayle; K V Blake
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 6.  Heliox for treatment of exacerbations of chronic obstructive pulmonary disease.

Authors:  G Rodrigo; C Pollack; C Rodrigo; B Rowe
Journal:  Cochrane Database Syst Rev       Date:  2002

7.  Two administration methods for inhaled salbutamol in intubated patients.

Authors:  S S Garner; D B Wiest; J W Bradley; D M Habib
Journal:  Arch Dis Child       Date:  2002-07       Impact factor: 3.791

8.  Acute severe asthma: new approaches to assessment and treatment.

Authors:  Spyros A Papiris; Effrosyni D Manali; Likurgos Kolilekas; Christina Triantafillidou; Iraklis Tsangaris
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 9.  Bridging the Gap Between Science and Clinical Efficacy: Physiology, Imaging, and Modeling of Aerosols in the Lung.

Authors:  Chantal Darquenne; John S Fleming; Ira Katz; Andrew R Martin; Jeffry Schroeter; Omar S Usmani; Jose Venegas; Otmar Schmid
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2016-02-01       Impact factor: 2.849

10.  Methods for evaluation of helium/oxygen delivery through non-rebreather facemasks.

Authors:  Andrew R Martin; Ira M Katz; Yonatan Lipsitz; Karine Terzibachi; Georges Caillibotte; Joëlle Texereau
Journal:  Med Gas Res       Date:  2012-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.